Uridine-derived ribose fuels glucose-restricted pancreatic cancer

Authors

Zeribe C Nwosu, University of Michigan - Ann Arbor
Matthew H Ward, Washington University School of Medicine in St. Louis
Leah P Shriver, Washington University School of Medicine in St. Louis
Gary J Patti, Washington University School of Medicine in St. Louis
et al.

Journal

Nature

Publication Date

6-1-2023

Volume

618

Issue

7963

First Page

151

Last Page

158

Document Type

Open Access Publication

DOI

10.1038/s41586-023-06073-w

Rights and Permissions

Nwosu, Z.C., Ward, M.H., Sajjakulnukit, P. et al. Uridine-derived ribose fuels glucose-restricted pancreatic cancer. Nature 618, 151–158 (2023). https://doi.org/10.1038/s41586-023-06073-w Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Nwosu, Zeribe C; Ward, Matthew H; Shriver, Leah P; Patti, Gary J; and et al., "Uridine-derived ribose fuels glucose-restricted pancreatic cancer." Nature. 618, 7963. 151 - 158. (2023).
https://digitalcommons.wustl.edu/oa_4/2298

Additional Links

Supplemental material is available for this article at publisher site.